Neimeth International Pharmaceuticals (NEIMETH)

Nigerian Exchange · Healthcare
Set a free alert

Up 19.6% over the past year. No dividend paid in the last 12 months.

₦6.70-1.47%Close on 2 Nov 2026
1-year change+19.64%
2.55.07.510.012.515.0Jan 26MarMayJulSep

Closing price in naira.

52-week range
₦4.95₦14.70
Dividends, last 12 months
-
Dividend yield
-
Market cap
₦32.7 billion

NEIMETH at a glance

Neimeth International Pharmaceuticals (NEIMETH) last closed at ₦6.70 on 2 Nov 2026, down 1.47% on the day. Over the past year the share price is up 19.6%, trading between ₦4.95 and ₦14.70. Neimeth International Pharmaceuticals has not paid a dividend in the last 12 months, based on the declarations we track. In FY 2025, Neimeth International Pharmaceuticals made a profit after tax of ₦976.4 million on revenue of ₦7.4 billion. That is a 37.2% return on shareholders' equity. At the latest price the shares trade at 33.5 times those earnings.

NEIMETH financials

From the accounts Neimeth International Pharmaceuticals filed with the NGX. At ₦6.70: P/E 33.5x, price to book 12.45x on FY 2025 earnings.

H1 2026FY 2025
Revenue₦3.7bn₦7.4bn
Profit after tax₦207.7m₦976.4m
Net profit margin5.7%13.3%
Return on equity14.6%37.2%
Earnings per share₦0.05₦0.23
All figures, and what each one means

Neimeth International Pharmaceuticals dividends

Qualification dateTypePaidPer share
14 Mar 202212M24 Mar 2022₦0.07

Questions about NEIMETH

What is the NEIMETH share price today?

Neimeth International Pharmaceuticals (NEIMETH) last closed at ₦6.70 on the Nigerian Exchange on 2 Nov 2026. Prices update after each trading day.

Does Neimeth International Pharmaceuticals pay dividends?

Yes. Neimeth International Pharmaceuticals has paid dividends; the most recent was ₦0.07 per share (12M) with a qualification date of 14 Mar 2022.

When is the next NEIMETH dividend?

No upcoming dividend has been declared yet. Onbourd Alerts can notify you when one is announced.

Is Neimeth International Pharmaceuticals profitable?

In FY 2025, Neimeth International Pharmaceuticals made a profit after tax of ₦976.4 million on revenue of ₦7.4 billion. That is a 37.2% return on shareholders' equity. At the latest price the shares trade at 33.5 times those earnings.

Prices are official NGX daily closes; dividends are declarations confirmed by Onbourd Alerts. Educational market information, not investment advice. Past performance does not guarantee future results.